Reports for APOTEX INC
Company Name APOTEX INC |
||
|---|---|---|
Totals |
||
Shortage reports |
3367 |
|
| Actual shortage: | 219 (7%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 3138 (93%) | |
Discontinuation Reports |
365 |
|
| To be discontinued: | 24 (7%) | |
| Discontinued: | 341 (93%) | |
| Reversed: | 0 (0%) | |
Late reports |
144 (4%) |
|
Overdue reports |
68 (28%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-RIVASTIGMINE | 1.5MG | CAPSULE | Resolved | 2017-09-04 | 2019-10-15 | 20900 |
| APO-RIVASTIGMINE | 4.5MG | CAPSULE | Resolved | 2018-01-22 | 2018-01-22 | 36947 |
| APO-RIVASTIGMINE | 4.5MG | CAPSULE | Resolved | 2018-01-22 | 2018-03-27 | 36949 |
| APO-RIVASTIGMINE | 1.5MG | CAPSULE | Resolved | 2024-03-08 | 2024-05-10 | 221729 |
| APO-RIVASTIGMINE | 4.5MG | CAPSULE | Actual shortage | 2025-01-23 | 2025-02-06 | 248492 |
| APO-RIVASTIGMINE | 1.5MG | CAPSULE | Actual shortage | 2025-02-13 | 2025-02-13 | 250310 |
| APO-RIVASTIGMINE | 6MG | CAPSULE | Actual shortage | 2025-03-20 | 2025-03-20 | 253075 |
| APO-RIZATRIPTAN | 10MG | TABLET | Resolved | 2024-12-12 | 2025-01-24 | 245511 |
| APO-RIZATRIPTAN | 5MG | TABLET | Resolved | 2025-01-16 | 2025-01-24 | 247859 |
| APO-RIZATRIPTAN | 10MG | TABLET | Resolved | 2025-04-04 | 2025-04-11 | 254169 |
| APO-RIZATRIPTAN | 10MG | TABLET | Resolved | 2017-03-11 | 2017-08-18 | 504 |
| APO-RIZATRIPTAN | 10MG | TABLET | Resolved | 2024-08-22 | 2024-11-22 | 235698 |
| APO-RIZATRIPTAN | 5MG | TABLET | Resolved | 2020-07-08 | 2020-08-21 | 119770 |
| APO-RIZATRIPTAN | 5MG | TABLET | Resolved | 2018-11-16 | 2019-05-06 | 67031 |
| APO-RIZATRIPTAN | 5MG | TABLET | Resolved | 2021-09-17 | 2021-11-08 | 145843 |
| APO-RIZATRIPTAN | 10MG | TABLET | Resolved | 2022-08-11 | 2022-10-14 | 166439 |
| APO-RIZATRIPTAN | 5MG | TABLET | Resolved | 2022-09-09 | 2022-10-14 | 169057 |
| APO-RIZATRIPTAN | 5MG | TABLET | Resolved | 2017-07-04 | 2018-01-10 | 14560 |
| APO-RIZATRIPTAN | 10MG | TABLET | Resolved | 2018-02-05 | 2019-05-06 | 38491 |
| APO-RIZATRIPTAN | 5MG | TABLET | Resolved | 2023-06-23 | 2023-06-29 | 196303 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-TIMOP | 0.5% | SOLUTION | Discontinued | 2019-01-03 | 2019-01-03 | 70894 |
| APO-TIMOP GEL | Discontinued | 2019-01-03 | 2019-01-03 | 71020 | ||
| APO-TIMOP OPH SOLN 0.25% | Discontinued | 2019-01-02 | 2019-01-02 | 70818 | ||
| APO-TOLTERODINE | 1MG | TABLET | Discontinued | 2018-09-08 | 2019-01-17 | 60822 |
| APO-TOLTERODINE | 2MG | TABLET | Discontinued | 2018-09-08 | 2018-11-09 | 60825 |
| APO-TOLTERODINE | 2MG | TABLET | Discontinued | 2018-09-08 | 2019-06-12 | 60828 |
| APO-TRAZODONE TABLETS 100MG | 100MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60831 |
| APO-TRAZODONE TABLETS 50MG | 50MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60834 |
| APO-VALACYCLOVIR | 500MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60840 |
| APO-VALGANCICLOVIR | 450MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60843 |
| APO-VALPROIC ACID ORAL SOLUTION | 250MG | SOLUTION | Discontinued | 2023-09-26 | 2023-11-02 | 205310 |
| APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71029 | ||
| APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71032 | ||
| APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71035 | ||
| APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71038 | ||
| APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71044 | ||
| APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71048 | ||
| APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71051 | ||
| APO-VALSARTAN/HCTZ | 12.5MG 160MG | TABLET | Discontinued | 2019-01-03 | 2019-01-03 | 71054 |
| APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71057 |